| Literature DB >> 31130869 |
Catarina Rosado1, Viviane Kaori Tokunaga2, Rafael Sauce2, Camila Areias de Oliveira2, Fernanda Daud Sarruf3, Roberto Parise-Filho2, Elisabete Maurício1, Tânia Santos de Almeida1, Maria Valéria Robles Velasco2, André Rolim Baby2.
Abstract
The excessive exposure to ultraviolet (UV) radiation is the main cause of skin cancer, the most commonly diagnosed cancer in the world. In this context, the development of innovative and more effective sunscreens, with bioactive compounds like caffeine, displaying antioxidant and anticancer potential, is required. This research work assessed in vitro and in vivo the efficacy and safety of topical sunscreen formulations containing caffeine as an adjuvant of the UV filters. Sunscreens were prepared with 2.5% w/w caffeine or in the absence of this compound. In order to evaluate the safety of these formulations, stratum corneum hydration, skin barrier and colorimetry were assessed in vivo in healthy subjects before and after skin treatment with the samples. The efficacy of the sunscreens was assessed in vitro, using PMMA plates and a spectrophotometer equipped with an integrating sphere; and in vivo by the determination of the sun protection factor (SPF). None of the formulations caused erythema or impaired the skin barrier function. The in vitro functional characterization showed higher SPF values for the caffeine formulation. The in vivo studies also confirmed the higher SPF value of the formulation combining caffeine with the filters, compared to the caffeine-free sample. This improvement contributed to an increase of, approximately, 25% in the in vivo anti-UVB protection. In conclusion, caffeine was well tolerated by the skin and increased the photoprotective activity, being a new alternative adjuvant in sunscreens formulation.Entities:
Keywords: UV radiation; caffeine; cutaneous compatibility; sun protection factor; sunscreen
Year: 2019 PMID: 31130869 PMCID: PMC6509748 DOI: 10.3389/fphys.2019.00519
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Chemical structure of caffeine (1).
Active ingredient composition (% w/w) of sunscreens.
| Compositiona | Concentration (% w/w) Formulation | |
|---|---|---|
| Caffeine free | 2.5% Caffeine | |
| 7.5 | 7.5 | |
| 3.0 | 3.0 | |
| 5.0 | 5.0 | |
| – | 2.5 | |
FIGURE 2Variation in stratum corneum (SC) hydration before and after application of the different formulations. The results were analyzed as the ratio between the values obtained after patch application over the basal values. Different letters for the same parameter indicate statistically significant differences between samples (p < 0.05; mean + SD, n = 12).
FIGURE 3Variation in transepidermal water loss before and after application of the different formulations. The results were analyzed as the ratio between the values obtained after patch application over the basal values. Different letters for the same parameter indicate statistically significant differences between samples (p < 0.05; mean + SD, n = 12).
FIGURE 4Variation in skin redness before and after application of the different formulations. The results were analyzed as the ratio between the values obtained after patch application over the basal values. Different letters for the same parameter indicate statistically significant differences between samples (p < 0.05; mean + SD, n = 12).
In vitro SPF and critical wavelength (nm) values (mean and standard deviation) as a function of irradiation time.
| Caffeine-free | 2.5% of caffeine | |||
|---|---|---|---|---|
| Irradiation time | SPF | Critical wavelength (nm) | SPF | critical wavelength (nm) |
| 29.0 ± 0.0 | 378 ± 0.0 | 38.5 ± 2.1 | 379 ± 0.0 | |
| 36.0 ± 0.0 | 377 ± 0.0 | 51.0 ± 0.0 | 378 ± 0.0 | |
In vivo SPF.
| Sample | |
|---|---|
| Caffeine-free | 15.49 ± 0.39 |
| 2.5% Caffeine | 19.34 ± 0.34 |
FIGURE 5Degradation reaction of caffeine (1). The photolytic degradation mechanism of caffeine (1) to dimethylparabanic acid (2) involves the hydroxy radical attack on caffeine’s double bond D4,8. Hydroxylation and subsequent oxidation processes generate compounds 2 and 3, which the substances CO2, NH3, and NH2Me are formed more slowly. Noteworthy, the oxidation products 4, 5, and 6 may also be converted into dimethylparabanic acid (2) via a similar mechanism.
FIGURE 6Metabolic pathways for caffeine (1). In blue, positions that suffered metabolic reactions.